• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鼠冠状病毒通过寡聚腺苷酸合成酶-RNase L 途径对细胞类型的特异性激活。

Cell-type-specific activation of the oligoadenylate synthetase-RNase L pathway by a murine coronavirus.

机构信息

Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

出版信息

J Virol. 2013 Aug;87(15):8408-18. doi: 10.1128/JVI.00769-13. Epub 2013 May 22.

DOI:10.1128/JVI.00769-13
PMID:23698313
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3719824/
Abstract

Previous studies have demonstrated that the murine coronavirus mouse hepatitis virus (MHV) nonstructural protein 2 (ns2) is a 2',5'-phosphodiesterase that inhibits activation of the interferon-induced oligoadenylate synthetase (OAS)-RNase L pathway. Enzymatically active ns2 is required for efficient MHV replication in macrophages, as well as for the induction of hepatitis in C57BL/6 mice. In contrast, following intranasal or intracranial inoculation, efficient replication of MHV in the brain is not dependent on an enzymatically active ns2. The replication of wild-type MHV strain A59 (A59) and a mutant with an inactive phosphodiesterase (ns2-H126R) was assessed in primary hepatocytes and primary central nervous system (CNS) cell types-neurons, astrocytes, and oligodendrocytes. A59 and ns2-H126R replicated with similar kinetics in all cell types tested, except macrophages and microglia. RNase L activity, as assessed by rRNA cleavage, was induced by ns2-H126R, but not by A59, and only in macrophages and microglia. Activation of RNase L correlated with the induction of type I interferon and the consequent high levels of OAS mRNA induced in these cell types. Pretreatment of nonmyeloid cells with interferon restricted A59 and ns2-H126R to the same extent and failed to activate RNase L following infection, despite induction of OAS expression. However, rRNA degradation was induced by treatment of astrocytes or oligodendrocytes with poly(I·C). Thus, RNase L activation during MHV infection is cell type specific and correlates with relatively high levels of expression of OAS genes, which are necessary but not sufficient for induction of an effective RNase L antiviral response.

摘要

先前的研究表明,鼠冠状病毒鼠肝炎病毒(MHV)非结构蛋白 2(ns2)是一种 2',5'-磷酸二酯酶,可抑制干扰素诱导的寡聚腺苷酸合成酶(OAS)-RNase L 途径的激活。具有酶活性的 ns2 是 MHV 在巨噬细胞中有效复制所必需的,也是在 C57BL/6 小鼠中诱导肝炎所必需的。相比之下,在鼻内或颅内接种后,MHV 在大脑中的有效复制并不依赖于具有酶活性的 ns2。野生型 MHV 株 A59(A59)和具有无磷酸二酯酶活性的突变体(ns2-H126R)的复制在原代肝细胞和原代中枢神经系统(CNS)细胞类型-神经元、星形胶质细胞和少突胶质细胞中进行了评估。除了巨噬细胞和小胶质细胞外,A59 和 ns2-H126R 在所有测试的细胞类型中以相似的动力学复制。ns2-H126R 诱导了 RNase L 活性,如 rRNA 切割所评估的那样,但 A59 没有诱导,并且仅在巨噬细胞和小胶质细胞中诱导。RNase L 的激活与 I 型干扰素的诱导以及这些细胞类型中诱导的 OAS mRNA 的高水平相关。非髓样细胞用干扰素预处理限制了 A59 和 ns2-H126R 的复制程度相同,并且在感染后未能激活 RNase L,尽管诱导了 OAS 表达。然而,用 poly(I·C)处理星形胶质细胞或少突胶质细胞可诱导 rRNA 降解。因此,MHV 感染期间 RNase L 的激活是细胞类型特异性的,并与 OAS 基因的相对高水平表达相关,这是诱导有效的 RNase L 抗病毒反应所必需的,但不是充分的。

相似文献

1
Cell-type-specific activation of the oligoadenylate synthetase-RNase L pathway by a murine coronavirus.鼠冠状病毒通过寡聚腺苷酸合成酶-RNase L 途径对细胞类型的特异性激活。
J Virol. 2013 Aug;87(15):8408-18. doi: 10.1128/JVI.00769-13. Epub 2013 May 22.
2
Antagonism of RNase L Is Required for Murine Coronavirus Replication in Kupffer Cells and Liver Sinusoidal Endothelial Cells but Not in Hepatocytes.核糖核酸酶L的拮抗作用是鼠冠状病毒在库普弗细胞和肝窦内皮细胞中复制所必需的,但在肝细胞中并非如此。
J Virol. 2016 Oct 14;90(21):9826-9832. doi: 10.1128/JVI.01423-16. Print 2016 Nov 1.
3
Activation of RNase L by Murine Coronavirus in Myeloid Cells Is Dependent on Basal Oas Gene Expression and Independent of Virus-Induced Interferon.小鼠冠状病毒在髓样细胞中激活RNase L依赖于基础Oas基因表达且独立于病毒诱导的干扰素。
J Virol. 2016 Jan 6;90(6):3160-72. doi: 10.1128/JVI.03036-15.
4
Homologous 2',5'-phosphodiesterases from disparate RNA viruses antagonize antiviral innate immunity.来自不同 RNA 病毒的同源 2',5'-磷酸二酯酶拮抗抗病毒先天免疫。
Proc Natl Acad Sci U S A. 2013 Aug 6;110(32):13114-9. doi: 10.1073/pnas.1306917110. Epub 2013 Jul 22.
5
Lineage A Betacoronavirus NS2 Proteins and the Homologous Torovirus Berne pp1a Carboxy-Terminal Domain Are Phosphodiesterases That Antagonize Activation of RNase L.A 型β冠状病毒 NS2 蛋白及同源的伯尔尼环曲病毒 pp1a 羧基末端结构域是拮抗 RNase L 激活的磷酸二酯酶。
J Virol. 2017 Feb 14;91(5). doi: 10.1128/JVI.02201-16. Print 2017 Mar 1.
6
Antagonism of the interferon-induced OAS-RNase L pathway by murine coronavirus ns2 protein is required for virus replication and liver pathology.干扰素诱导的 OAS-RNase L 途径拮抗作用被鼠冠状病毒 ns2 蛋白拮抗,这是病毒复制和肝脏病理所必需的。
Cell Host Microbe. 2012 Jun 14;11(6):607-16. doi: 10.1016/j.chom.2012.04.011.
7
Murine AKAP7 has a 2',5'-phosphodiesterase domain that can complement an inactive murine coronavirus ns2 gene.小鼠AKAP7具有一个2',5'-磷酸二酯酶结构域,该结构域可补充无活性的小鼠冠状病毒ns2基因。
mBio. 2014 Jul 1;5(4):e01312-14. doi: 10.1128/mBio.01312-14.
8
Rotavirus NSP1 Subverts the Antiviral Oligoadenylate Synthetase-RNase L Pathway by Inducing RNase L Degradation.轮状病毒 NSP1 通过诱导 RNase L 降解来颠覆抗病毒寡聚腺苷酸合成酶-RNase L 途径。
mBio. 2022 Dec 20;13(6):e0299522. doi: 10.1128/mbio.02995-22. Epub 2022 Nov 22.
9
Organ-specific attenuation of murine hepatitis virus strain A59 by replacement of catalytic residues in the putative viral cyclic phosphodiesterase ns2.通过替换假定的病毒环磷酸二酯酶ns2中的催化残基对鼠肝炎病毒A59株进行器官特异性减毒。
J Virol. 2009 Apr;83(8):3743-53. doi: 10.1128/JVI.02203-08. Epub 2009 Jan 28.
10
Rotavirus Controls Activation of the 2'-5'-Oligoadenylate Synthetase/RNase L Pathway Using at Least Two Distinct Mechanisms.轮状病毒至少通过两种不同机制控制2'-5'-寡腺苷酸合成酶/RNase L途径的激活。
J Virol. 2015 Dec;89(23):12145-53. doi: 10.1128/JVI.01874-15. Epub 2015 Sep 23.

引用本文的文献

1
Human coronaviruses: activation and antagonism of innate immune responses.人类冠状病毒:先天免疫反应的激活与拮抗
Microbiol Mol Biol Rev. 2025 Mar 27;89(1):e0001623. doi: 10.1128/mmbr.00016-23. Epub 2024 Dec 19.
2
Recurrent viral capture of cellular phosphodiesterases that antagonize OAS-RNase L.细胞磷酸二酯酶的反复病毒捕获对抗OAS-RNase L。
Proc Natl Acad Sci U S A. 2024 Jan 30;121(5):e2312691121. doi: 10.1073/pnas.2312691121. Epub 2024 Jan 26.
3
The Impact of Innate Components on Viral Pathogenesis in the Neurotropic Coronavirus Encephalomyelitis Mouse Model.先天成分对嗜神经冠状病毒脑炎小鼠模型中病毒发病机制的影响。
Viruses. 2023 Dec 9;15(12):2400. doi: 10.3390/v15122400.
4
Recurrent Viral Capture of Cellular Phosphodiesterases that Antagonize OAS-RNase L.细胞磷酸二酯酶的反复病毒捕获对抗OAS-RNase L
bioRxiv. 2023 Sep 14:2023.05.12.540623. doi: 10.1101/2023.05.12.540623.
5
2-5A-Mediated decay (2-5AMD): from antiviral defense to control of host RNA.2-5A 介导的降解(2-5AMD):从抗病毒防御到宿主 RNA 的控制。
Crit Rev Biochem Mol Biol. 2022 Oct-Dec;57(5-6):477-491. doi: 10.1080/10409238.2023.2181308. Epub 2023 Mar 20.
6
Inborn errors of OAS-RNase L in SARS-CoV-2-related multisystem inflammatory syndrome in children.儿童 SARS-CoV-2 相关多系统炎症综合征中的 OAS-RNase L 先天性错误。
Science. 2023 Feb 10;379(6632):eabo3627. doi: 10.1126/science.abo3627.
7
MERS-CoV endoribonuclease and accessory proteins jointly evade host innate immunity during infection of lung and nasal epithelial cells.中东呼吸综合征冠状病毒内切核酸酶和辅助蛋白在感染肺和鼻腔上皮细胞过程中共同逃避宿主固有免疫。
Proc Natl Acad Sci U S A. 2022 May 24;119(21):e2123208119. doi: 10.1073/pnas.2123208119. Epub 2022 May 20.
8
Interferon Control of Human Coronavirus Infection and Viral Evasion: Mechanistic Insights and Implications for Antiviral Drug and Vaccine Development.干扰素对人冠状病毒感染的控制和病毒逃逸:作用机制的洞察及其对抗病毒药物和疫苗开发的意义。
J Mol Biol. 2022 Mar 30;434(6):167438. doi: 10.1016/j.jmb.2021.167438. Epub 2022 Jan 3.
9
Immune mediating molecules and pathogenesis of COVID-19-associated neurological disease.COVID-19 相关神经疾病的免疫介导分子和发病机制。
Microb Pathog. 2021 Sep;158:105023. doi: 10.1016/j.micpath.2021.105023. Epub 2021 Jun 4.
10
SARS-CoV-2 induces double-stranded RNA-mediated innate immune responses in respiratory epithelial-derived cells and cardiomyocytes.SARS-CoV-2 诱导呼吸道上皮细胞和心肌细胞中双链 RNA 介导的先天免疫反应。
Proc Natl Acad Sci U S A. 2021 Apr 20;118(16). doi: 10.1073/pnas.2022643118.

本文引用的文献

1
Differential innate immune response programs in neuronal subtypes determine susceptibility to infection in the brain by positive-stranded RNA viruses.不同神经元亚型的固有免疫反应程序决定了其对正链 RNA 病毒感染大脑的易感性。
Nat Med. 2013 Apr;19(4):458-64. doi: 10.1038/nm.3108. Epub 2013 Mar 3.
2
Oligodendroglia are limited in type I interferon induction and responsiveness in vivo.少突胶质细胞在体内的 I 型干扰素诱导和反应能力上受到限制。
Glia. 2012 Oct;60(10):1555-66. doi: 10.1002/glia.22375. Epub 2012 Jun 26.
3
Antagonism of the interferon-induced OAS-RNase L pathway by murine coronavirus ns2 protein is required for virus replication and liver pathology.干扰素诱导的 OAS-RNase L 途径拮抗作用被鼠冠状病毒 ns2 蛋白拮抗,这是病毒复制和肝脏病理所必需的。
Cell Host Microbe. 2012 Jun 14;11(6):607-16. doi: 10.1016/j.chom.2012.04.011.
4
Interferon-induced Ifit2/ISG54 protects mice from lethal VSV neuropathogenesis.干扰素诱导的 Ifit2/ISG54 保护小鼠免受致死性 VSV 神经发病机制的影响。
PLoS Pathog. 2012;8(5):e1002712. doi: 10.1371/journal.ppat.1002712. Epub 2012 May 17.
5
Visualizing coronavirus RNA synthesis in time by using click chemistry.通过点击化学技术实时可视化冠状病毒 RNA 合成。
J Virol. 2012 May;86(10):5808-16. doi: 10.1128/JVI.07207-11. Epub 2012 Mar 21.
6
Coronavirus pathogenesis.冠状病毒发病机制。
Adv Virus Res. 2011;81:85-164. doi: 10.1016/B978-0-12-385885-6.00009-2.
7
Cell-type-specific type I interferon antagonism influences organ tropism of murine coronavirus.细胞类型特异性 I 型干扰素拮抗作用影响鼠冠状病毒的器官嗜性。
J Virol. 2011 Oct;85(19):10058-68. doi: 10.1128/JVI.05075-11. Epub 2011 Jul 13.
8
Canonical Wnt signalling requires the BMP pathway to inhibit oligodendrocyte maturation.经典 Wnt 信号通路需要 BMP 通路来抑制少突胶质细胞成熟。
ASN Neuro. 2011 Jun 16;3(3):e00061. doi: 10.1042/AN20110004.
9
Development and RNA-synthesizing activity of coronavirus replication structures in the absence of protein synthesis.冠状病毒复制结构在没有蛋白质合成的情况下的发育和 RNA 合成活性。
J Virol. 2011 Jun;85(11):5669-73. doi: 10.1128/JVI.00403-11. Epub 2011 Mar 23.
10
Autocrine interferon priming in macrophages but not dendritic cells results in enhanced cytokine and chemokine production after coronavirus infection.自分泌干扰素在巨噬细胞中而不是树突状细胞中引发预刺激,导致冠状病毒感染后细胞因子和趋化因子的产生增强。
mBio. 2010 Oct 19;1(4):e00219-10. doi: 10.1128/mBio.00219-10.